Geode Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.29M Buy
268,273
+4,713
+2% +$116K ﹤0.01% 2479
2025
Q4
$5.5M Sell
263,560
-5,793
-2% -$108K ﹤0.01% 2714
2025
Q3
$4.23M Sell
269,353
-2,904
-1% -$59.9K ﹤0.01% 2869
2025
Q2
$5.41M Buy
272,257
+192,770
+243% +$3.91M ﹤0.01% 2687
2025
Q1
$1.41M Buy
79,487
+1,903
+2% +$62K ﹤0.01% 3179
2024
Q4
$3.58M Buy
77,584
+705
+0.9% +$29.8K ﹤0.01% 2906
2024
Q3
$2.33M Buy
76,879
+45,846
+148% +$838K ﹤0.01% 3076
2024
Q2
$511K Sell
31,033
-4
-0% -$64 ﹤0.01% 3559
2024
Q1
$477K Buy
31,037
+494
+2% +$7.82K ﹤0.01% 3636
2023
Q4
$499K Buy
30,543
+1,117
+4% +$19.2K ﹤0.01% 3612
2023
Q3
$544K Buy
29,426
+781
+3% +$13.8K ﹤0.01% 3570
2023
Q2
$327K Buy
28,645
+1,102
+4% +$12.5K ﹤0.01% 3818
2023
Q1
$331K Sell
27,543
-4,617
-14% -$64.3K ﹤0.01% 3812
2022
Q4
$275K Sell
32,160
-78
-0.2% -$686 ﹤0.01% 3931
2022
Q3
$248K Hold
32,238
﹤0.01% 4080
2022
Q2
$355K Sell
32,238
-29,902
-48% -$352K ﹤0.01% 3946
2022
Q1
$984K Buy
62,140
+7,956
+15% +$164K ﹤0.01% 3626
2021
Q4
$2.5M Buy
54,184
+6,110
+13% +$351K ﹤0.01% 3269
2021
Q3
$3.22M Sell
48,074
-3,748
-7% -$308K ﹤0.01% 3154
2021
Q2
$5.53M Buy
51,822
+2,179
+4% +$258K ﹤0.01% 2827
2021
Q1
$7.56M Buy
49,643
+7,401
+18% +$1.2M ﹤0.01% 2550
2020
Q4
$7.07M Buy
42,242
+6,686
+19% +$1.19M ﹤0.01% 2399
2020
Q3
$5.55M Buy
35,556
+871
+3% +$175K ﹤0.01% 2328
2020
Q2
$7.26M Buy
34,685
+4,922
+17% +$1.01M ﹤0.01% 2116
2020
Q1
$5.56M Buy
29,763
+5,097
+21% +$1.2M ﹤0.01% 2084
2019
Q4
$5.96M Buy
24,666
+1,455
+6% +$281K ﹤0.01% 2345
2019
Q3
$3.93M Buy
23,211
+10,946
+89% +$2.48M ﹤0.01% 2526
2019
Q2
$2.39M Buy
12,265
+1,911
+18% +$412K ﹤0.01% 2833
2019
Q1
$2.74M Buy
10,354
+3,169
+44% +$579K ﹤0.01% 2666
2018
Q4
$1.44M Buy
7,185
+1,729
+32% +$527K ﹤0.01% 2944
2018
Q3
$3.4M Buy
+5,456
New +$2.42M ﹤0.01% 2604

Other funds holding TECX